Vaccino pneumococcico coniugato- Bandi per la Ricerca Indipendente

from Salute e Società · host Marco Caracciolo

1. MSD annuncia i dati positivi su V116, il vaccino pneumococcico coniugato 21-valente in sviluppo, il primo specificatamente progettato per gli adulti, che ha mostrato risposte immunitarie significative nella popolazione adulta. 2. 30 i vincitori da tutta Italia per un investimento totale di 940mila euro: 8 ricercatori under 40 dal bando “Fondazione Roche per la ricerca indipendente”.

Episode metadata supplied by the publisher feed · Published Apr 12, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Vaccino pneumococcico coniugato- Bandi per la Ricerca Indipendente

0:00 5:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Salute e Società?

This episode is 5 minutes long.

When was this Salute e Società episode published?

This episode was published on April 12, 2024.

Can I download this Salute e Società episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!